Understanding physician agreement with varicella immunization guidelines.

Prev Med

Department of Family Medicine and Clinical Epidemiology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.

Published: August 2002

Background: Although varicella vaccine was licensed in 1995, immunization rates are only moderate. This study identifies factors associated with physician self-reported likelihood of recommending varicella vaccination to patients.

Methods: Two hundred eighty-one Minnesota and Pennsylvania primary care physicians who participated in surveys on barriers to vaccination in 1990-1991 and 1993 were surveyed in 1999, assessing physicians' beliefs about varicella disease and vaccine and their self-reported likelihood of recommending varicella vaccine to three age groups of children.

Results: Most (79, 80, and 83%) were likely to recommend varicella vaccine for 12- to 18-month old, 4- to 6-year-old, and 11- to 12-year old children, respectively, and most (78%) agreed with national recommendations to vaccinate. If physicians believed that the vaccine would fail, they were less likely to recommend varicella vaccination for 12- to 18-month-old (70% vs 85%, P = 0.001) and 4- to 6-year-old (83% vs 85%, P = 0.001) children, than if they believed in its efficacy. Pediatricians were more likely to recommend varicella vaccine than were family physicians and general practitioners (P < 0.01).

Conclusions: Physicians, especially pediatricians, report that they recommend varicella vaccination when they agree with national recommendations, believe in the efficacy of the vaccine, and perceive that parents want the vaccine for their children.

Download full-text PDF

Source
http://dx.doi.org/10.1006/pmed.2002.1068DOI Listing

Publication Analysis

Top Keywords

varicella vaccine
16
recommend varicella
16
varicella vaccination
12
varicella
9
vaccine
8
self-reported likelihood
8
likelihood recommending
8
recommending varicella
8
national recommendations
8
85% 0001
8

Similar Publications

Disseminated Chickenpox Following Live Varicella Vaccination in a Crohn's Disease Patient on Combination Immunosuppression.

Case Rep Gastrointest Med

January 2025

Department of Gastroenterology and Hepatology, Michigan Medicine, Ann Arbor, Michigan, USA.

Novel therapeutics used in the treatment of inflammatory bowel disease pose an increased risk of viral reactivation in patients. We present a case of a patient with refractory Crohn's disease (CD) who developed primary varicella (chickenpox) of a vaccine-viral strain after receiving combination immunosuppression with high-dose corticosteroids, tumor necrosis factor inhibitor (TNFi), and a Janus kinase inhibitor (JAKi) in the hospital. While this patient recovered and did not experience long term adverse effects, her case provides an opportunity for improvement.

View Article and Find Full Text PDF

Varicella presents a public health challenge in Guatemala, with limited evidence regarding its impact; vaccine is currently absent from the national immunization program. Generating local data on the economic and health burden can support immunization policies. This study describes the use of hospital resources, costs of care, clinical and demographic characteristics, and complications in children with varicella.

View Article and Find Full Text PDF

Background/objectives: Approved mRNA vaccines commonly use sequences modified with pseudouridine to enhance translation efficiency and mRNA stability. However, this modification can result in ribosomal frameshifts, reduced immunogenicity, and higher production costs. This study aimed to explore the potential of unmodified mRNA sequences for varicella-zoster virus (VZV) and evaluate whether codon optimization could overcome the limitations of pseudouridine modification.

View Article and Find Full Text PDF

: China has a high incidence rate of varicella yet a low coverage rate of the varicella vaccine (VarV), with safety concerns being a leading cause of the lack of vaccination willingness. This study aimed to describe VarV-related adverse events following immunization (AEFIs) and analyze their characteristics in Zhejiang, China, 2020-2022. : VarV-related AEFIs in Zhejiang Province from 1 January 2020 to 31 December 2022 were collected through the Chinese National AEFI Information System (CNAEFIS) for a descriptive epidemiological analysis.

View Article and Find Full Text PDF

Seropositivity study of Varicella in Healthy Populations in Guangzhou, China. Infection with varicella-zoster virus (VZV) leads to skin and mucous membranes blisters and the complications can be life threatening. A seroepidemiological study conducted from 2020 to 2022 in Guangzhou, China, aimed to evaluate varicella antibody levels.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!